Therapeutics involves patient care on disease prevention and treatment, and toxicology studies harmful or adverse effects of chemicals including medications.
Patients administer medications to manage or treat diseases, however, not all patients receive benefits from pharmacotherapy.
Our lab investigates factors associated with beneficial and harmful impacts of pharmacotherapy including medication efficacy & adverse events, patient and disease-specific factors, and healthcare services to acheive pharmacotherapy optimization, thereby promoting patient health and safety.
Risk versus Benefit Analysis on Pharmacotherapy
Pharmacotherapy Optimization in Special Populations
(Geriatrics, Pediatrics, Pregnancy & Lactation)
Personalized Pharmacotherapy
Drug Safety Analysis utilizing Real World Data (RWD)
Factorial Analysis on Adverse Events
Personalized Prevention Measures for Adverse Events
Liver Toxicity and Preventive Measure Experiments
Toxicity and Prevention Mechanisms
Clinical Benefits from Pharmacy-led Clinical Services
Multidisciplinary Quality Improvement Initiatives
FDA defines regulatory science as the science of developing new tools, standards, and approaches to assess safety, efficacy, quality, and performance of all FDA regulated products
Our lab aims to expand research areas to develop innovative tools to promote patient health and safety by applying novel research skills.
We believe we can overcome challenges through pursuing integrity.